Current Research Studies
Cancer - A031102: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Condition or Therapy:
Germ cell tumor, teratoma, choricarinoma, germinoma, yolk sac tumor
Cancer and Blood Disorders
Study Number: A031102
What is the goal of this study?
This study looks at how high-dose combination chemotherapy and stem cell transplant compares with standard-dose combination chemotherapy to treat patients with refractory or recurrent germ cell tumors.
Who can join the study?
This study may be a good fit for children and young adults who:
- are male,
- 14 years of age or older, and
- have progressive or recurrent germ cell tumors.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.